Myelodysplasia and leukemia of Fanconi anemia are associated with a specific pattern of genomic abnormalities that includes cryptic RUNX1/AML1 lesions

被引:139
作者
Quentin, Samuel [1 ,2 ,3 ]
Cuccuini, Wendy [1 ,2 ,3 ]
Ceccaldi, Raphael [1 ,2 ,3 ]
Nibourel, Olivier [4 ,5 ,6 ]
Pondarre, Corinne [7 ,8 ]
Pages, Marie-Pierre [9 ]
Vasquez, Nadia [1 ,2 ,3 ,10 ]
d'Enghien, Catherine Dubois [11 ]
Larghero, Jerome [12 ]
de Latour, Regis Peffault [10 ]
Rocha, Vanderson [10 ]
Dalle, Jean-Hugues [10 ,13 ,14 ]
Schneider, Pascale [15 ]
Michallet, Mauricette [9 ]
Michel, Gerard [16 ]
Baruchel, Andre [10 ,13 ,14 ]
Sigaux, Francois [1 ,2 ,3 ]
Gluckman, Eliane [10 ]
Leblanc, Thierry [10 ,13 ,14 ]
Stoppa-Lyonnet, Dominique [11 ]
Preudhomme, Claude [4 ,5 ,6 ]
Socie, Gerard [10 ]
Soulier, Jean [1 ,2 ,3 ,10 ]
机构
[1] Univ Paris 07, St Louis Hosp, AP HP, Hematol Lab,Team Genome & Canc, F-75010 Paris, France
[2] St Louis Hosp, INSERM, U944, Paris, France
[3] Univ Paris Diderot, Inst Univ Hematol, Paris, France
[4] Ctr Hosp Reg Univ Lille, Hematol Lab, Lille, France
[5] INSERM, U837, Team 3, F-59045 Lille, France
[6] Univ Lille Nord France, Lille, France
[7] Inst Hematol & Oncol Pediat, Lyon, France
[8] Univ Lyon 1, F-69365 Lyon, France
[9] Lyon Sud Hosp, Dept Hematol, Lyon, France
[10] French Natl Reference Ctr Constitut Bone Marrow F, Paris, France
[11] Inst Curie, Oncogenet Lab, Paris, France
[12] St Louis Hosp, Cell Therapy Unit, Paris, France
[13] Robert Debre Hosp, AP HP, Pediat Hematol Dept, Paris, France
[14] St Louis Hosp, AP HP, Pediat Hematol Dept, Paris, France
[15] Charles Nicolle Hosp, Dept Pediat Oncol, Rouen, France
[16] La Timone Hosp, Dept Pediat Hematol, Marseille, France
关键词
ACUTE MYELOID-LEUKEMIA; METHYLTRANSFERASE GENE EZH2; CYTOGENETIC ABNORMALITIES; PROGNOSTIC-SIGNIFICANCE; EX-VIVO; MUTATIONS; CELLS; RISK; OVEREXPRESSION; TRANSLOCATION;
D O I
10.1182/blood-2010-09-308726
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Fanconi anemia (FA) is a genetic condition associated with bone marrow (BM) failure, myelodysplasia (MDS), and acute myeloid leukemia (AML). We studied 57 FA patients with hypoplastic or aplastic anemia (n = 20), MDS (n = 18), AML (n = 11), or no BM abnormality (n = 8). BM samples were analyzed by karyotype, high-density DNA arrays with respect to paired fibroblasts, and by selected oncogene sequencing. A specific pattern of chromosomal abnormalities was found in MDS/AML, which included 1q+ (44.8%), 3q+ (41.4%), -7/7q (17.2%), and 11q- (13.8%). Moreover, cryptic RUNX1/AML1 lesions (translocations, deletions, or mutations) were observed for the first time in FA (20.7%). Rare mutations of NRAS, FLT3-ITD, MLL-PTD, ERG amplification, and ZFP36L2-PRDM16 translocation, but no TP53, TET2, CBL, NPM1, and CEBP alpha mutations were found. Frequent homozygosity regions were related not to somatic copy-neutral loss of heterozygosity but to consanguinity, suggesting that homologous recombination is not a common progression mechanism in FA. Importantly, the RUNX1 and other chromosomal/genomic lesions were found at the MDS/AML stages, except for 1q+, which was found at all stages. These data have implications for staging and therapeutic managing in FA patients, and also to analyze the mechanisms of clonal evolution and oncogenesis in a background of genomic instability and BM failure. (Blood. 2011; 117(15):e161-e170)
引用
收藏
页码:E161 / E170
页数:10
相关论文
共 51 条
[1]   Cancer in Fanconi anemia, 1927-2001 [J].
Alter, BP .
CANCER, 2003, 97 (02) :425-440
[2]   Fanconi anemia: Myelodysplasia as a predictor of outcome [J].
Alter, BP ;
Caruso, JP ;
Drachtman, RA ;
Uchida, T ;
Velagaleti, GVN ;
Elghetany, MT .
CANCER GENETICS AND CYTOGENETICS, 2000, 117 (02) :125-131
[3]  
[Anonymous], ATLAS GENET CYTOGENE
[4]  
[Anonymous], ATLAS GENET CYTOGENE
[5]   Fanconi anemia and its diagnosis [J].
Auerbach, Arleen D. .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2009, 668 (1-2) :4-10
[6]   Myelodysplasia and Acute Leukemia as Late Complications of Marrow Failure: Future Prospects for Leukemia Prevention [J].
Bagby, Grover C. ;
Meyers, Gabrielle .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2009, 23 (02) :361-+
[7]   HEMATOLOGIC ABNORMALITIES IN FANCONI-ANEMIA - AN INTERNATIONAL FANCONI-ANEMIA REGISTRY STUDY [J].
BUTTURINI, A ;
GALE, RP ;
VERLANDER, PC ;
ADLERBRECHER, B ;
GILLIO, AP ;
AUERBACH, AD .
BLOOD, 1994, 84 (05) :1650-1655
[8]   Spontaneous abrogation of the G2 DNA damage checkpoint has clinical benefits but promotes leukemogenesis in Fanconi anemia patients [J].
Ceccaldi, Raphael ;
Briot, Delphine ;
Larghero, Jerome ;
Vasquez, Nadia ;
d'Enghien, Catherine Dubois ;
Chamousset, Delphine ;
Noguera, Maria-Elena ;
Waisfisz, Quinten ;
Hermine, Olivier ;
Pondarre, Corinne ;
Leblanc, Thierry ;
Gluckman, Eliane ;
Joenje, Hans ;
Stoppa-Lyonnet, Dominique ;
Socie, Gerard ;
Soulier, Jean .
JOURNAL OF CLINICAL INVESTIGATION, 2011, 121 (01) :184-194
[9]   Diagnosis of Myelodysplastic Syndrome Among a Cohort of 119 Patients With Fanconi Anemia Morphologic and Cytogenetic Characteristics [J].
Cioc, Adina M. ;
Wagner, John E. ;
MacMillan, Margaret L. ;
DeFor, Todd ;
Hirsch, Betsy .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2010, 133 (01) :92-100
[10]   The C-MYB locus is involved in chromosomal translocation and genomic duplications in human T-cell acute leukemia (T-ALL), the translocation defining a new T-ALL subtype in very young children [J].
Clappier, Emmanuelle ;
Cuccuini, Wendy ;
Kalota, Anna ;
Crinquette, Antoine ;
Cayuela, Jean-Michel ;
Dik, Willem A. ;
Langerak, Anton W. ;
Montpellier, Bertrand ;
Nadel, Bertrand ;
Walrafen, Pierre ;
Delattre, Olivier ;
Aurias, Alain ;
Leblanc, Thierry ;
Dombret, Herve ;
Gewirtz, Alan M. ;
Baruchel, Andre ;
Sigaux, Francois ;
Soulier, Jean .
BLOOD, 2007, 110 (04) :1251-1261